Biogen Inc. buy UBS Group AG
Start price
24.07.23
/
50%
€249.60
Target price
24.07.24
€302.51
Performance (%)
-16.51%
End price
25.07.24
€208.40
Summary
This prediction ended on 25.07.24 with a price of €208.40. The prediction for Biogen Inc. disappointed with a performance of -16.51%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -3.457% | -3.457% | 2.089% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by UBS_Group_AG for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at UBS Group AG from $346.00 to $335.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten